
Many people exploring multi-angle strategies for cancer—triggered by resources like social media posts, books, websites, online programs or community forums—can end up with overwhelming and fragmented information. OncoIntegrate is an educational tool(not medical advice) that uses hypothesis-generating, preclinical evidence to help you structure your approach into a framework of 15 therapeutic categories.
OncoIntegrate translates complex integrative ideas into clear, customizable drafts:
OncoIntegrate does not diagnose, treat, or prescribe. It does not replace professional oncology care or clinical judgment. All content is educational in nature and must be reviewed with licensed healthcare professionals. All care decisions remain the responsibility of patients and their medical providers.
Compounds are tailored to your user profile, which includes information on your cancer type, stage, current cancer treatments, other medical conditions, current medications and supplements, allergies, and more.
Learn about the evidence for why the selected compounds were recommended for your cancer type, mutations, hormonal status, health conditions, and much more... Explore dosing, lab monitoring, side effects, and more.
Get evidence-informed recommendations on off-label drugs and supplements that have data supporting their potential use in targeting your cancer's molecular and genomic abnormalities.
The Press-Pulse Protocol Generator helps you create a plan that applies continuous metabolic “pressure” on cancer cells while periodically delivering short, higher-intensity pulses for added impact. The Ferroptosis Pulse Planner guides you in designing short bursts of pro-oxidant supports aimed at triggering a specific form of oxidative cancer cell death called ferroptosis. These tools translate complex metabolic oncology strategies into easy-to-follow schedules. They are intended to support informed conversations with your medical team.
This Protocol Builder organizes community-reported benzimidazole (mebendazole or fenbendazole) and ivermectin use into a structured, evidence-informed framework. It integrates safety screening, weight-based calculators, and AI-powered re-protocoling to create clear, professional-style reports. Users can explore published data, flag potential drug interactions, and generate monitoring checklists. This tool is designed to support informed conversations with oncology teams, bringing clarity and safety context to an area often filled with scattered or unreliable information.
Helps you make safer supplement and drug selections, while also taking into account your health conditions.
— OncoIntegrate User (August 2025)
— OncoIntegrate User (August 2025)